We have been working hard to enable Cerebellar Ataxia (CA) testing is available worldwide and we have some great news to share with you.

UK Only As you are aware Canine Genetics Testing (the Kennel Club Genetics Centre at the University of Cambridge) will be processing all the UK CA Swabs.

To order swabs for UK testing go to: UK CA SWAB TEST ORDER

Outside the UK Labogen is the EU laboratory that will process all swabs from countries outside the UK.

The Kennel Club Genetics Centre at the University of Cambridge have partnered with Laboklin whose European Laboratory will process the swabs.

To order your swabs for Worldwide testing go to: WORLDWIDE CA SWAB TEST ORDER

PLEASE email a copy of your results certificate to castatus@italianspinone.co.uk and your dog’s CA Status will be added to the ISCGB website and health database.

Continue reading “CA Testing News”

 

Championship and Open Show Results for 2022 …… Please email any show results to results@italianspinone.co.uk for inclusion on the website.

Visit our show photo archive at https://www.italianspinone.co.uk/coppermine  Here you can see all the pictures for your dog in one place.  Click Search and enter all or part of your dogs name excluding affixes, titles etc.  For example to see all the pictures for Sh Ch Inostricani Simoni del Michiamo you would enter Simoni in the search box F F F F F F F SHOW PHOTO ARCHIVE.

We may display photos from shows on our Website and Facebook page.  If any person does not wish to have their photos displayed please contact the Secretary (privacy@italianspinone.co.uk) and request that they are not displayed.

Continue reading “2022 Show Results”

CA Testing
The DNA testing service was approved by Cambridge University last week, and the genetics team can now begin the process of recruiting staff to perform this function. The Italian Spinone CA Test will not need development as they already have everything in place to run the assay, but it could take a few months before DNA testing service will be up and running whilst recruitment takes place.

Epilepsy Research
We will shortly be posting the pathway for collection of swabs to continue with our epilepsy research. Once this has been published we will be able to start sending out swab kits and the necessary documentation to those who have kindly volunteered their dog’s DNA for this research.

Elaine Kirkham, ISCGB Health Co-ordinator, June 2021.

 

The genetics team from the AHT are settling in at Cambridge and are hoping to get back to normal working very soon.

This will mean recommencing CA testing and also continuing the very important study into “The prevalence if Idiopathic Epilepsy in the Italian Spinone”

?Update from the genetics team at Cambridge?

Our scientists recently tested some more dogs for the genetic variants that we had identified from our genome scan as being potentially associated with IE, but our results suggest that we still do not have quite enough samples to be sure whether or not we can replicate this finding, and we need to be sure of this before we can take the study further. As such we are in great need of samples from dogs affected with IE and those over the age of 7 years with no report of seizure.

The team work very closely with Hannes Lohi’s group on epilepsy in several breeds and so any samples that go to him should be able to be shared with our KC genetics team, and vice versa. All of our AHT samples and the majority of data have travelled with us to Cambridge, so are still available.

Continue reading “News From Cambridge May 2021”

Canine lymphoma is a common cancer of the white blood cells [lymphocytes]. It typically presents as swelling of the lymph nodes [glands]. An owner will often first notice a swelling in the throat or groin. Both external and internal lymph glands are affected and tend to enlarge very quickly. The lymphoma may metastatise to other parts of the body. Less commonly lymphoma affects isolated organs of the body such as the spleen, liver, intestines or skin.

There are many different types of lymphoma which are classified by the type of lymphocytes affected. The two main groups are B and T cell lymphoma. The lymphoma type will determine the prognosis and most suitable chemotherapy protocol.
Without treatment the disease rapidly progresses with an average survival time of two months.
With treatment survival times can be increased to six to twelve months. Longer periods of remission have been achieved but are rare.

The incidence of cancers generally in our dogs appears to be increasing. However this may only be a reflection of better welfare and medicine increasing the life span of canine friends and hence the development of cancer in later life. In addition advances in medicine, particularly imaging techniques, means previous cases that would not have been detected are now diagnosed.

Regarding the cause of cancer there is still much to learn. It is generally thought to have a multifactorial aetiology but we do know that some types of cancer show a hereditary component. Lymphoma is one such cancer. Whilst it can occur spontaneously it also shows a genetic predisposition in certain dog breeds. Breeds affected include Retrievers, Rottweilers, Springer Spaniels, Boxers, Mastiffs and bull breeds. There are different subtypes of lymphoma within the different breeds.

The incidence of lymphoma in Italian Spinone appears to be increasing. There have been reports of more than one family member being affected. The ISCGB health committee with the help of Cambridge University are intending to correlate data to see if there is a possibility of a predisposition to lymphoma developing in our breed.

Please submit any information that you think may be helpful [in strict confidence] by clicking the Report Health button in the menu or click here.

The genetics team from the AHT have secured a laboratory at Cambridge University, contracts are still being negotiated between the University of Cambridge the Kennel club and Kennel Club Charitable Trust. They hope to be able to recommence the CA testing service in 2-3 months assuming things go smoothly with contracts and university appointments for the testing posts.

Since 2020 I have been in continued discussions with several other laboratories. There are now two of the original four laboratories that responded to my request for them to develop a DNA test for CA.
Dr Mellersh has offered her help and support with those two laboratories in the development of the test.

I have forwarded Dr Mellersh’s contact details to the laboratories, we are now awaiting their decisions. Both laboratories will require affected, carrier and control samples to properly validate the test and will have to develop the test from scratch which may have a financial implication, even if this is added to the cost of the test once developed.

Once they have consulted with Dr Mellersh we will have a better idea of costs and timescales involved in developing new tests.

Elaine Kirkham
ISCGB Health Co-ordinator
March 2021